Study: Combination therapy is effective for biliary-tract cancers

11/24/2009 | Modern Medicine

A study involving advanced biliary-tract cancer patients showed that combining bevacizumab with gemcitabine and oxaliplatin treatment improved disease management and increased progression-free and overall survival. Scans using 18FDG-PET showed a drop in maximum standardized uptake value following two treatment rounds, which helped predict progression-free and overall survival.

View Full Article in:

Modern Medicine

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC